A man charged with contempt of court for failing to hand over infringing products in a trade mark case won by electrical goods manufacturer Clipsal Australia gets six more months to pay his outstanding fine, or he goes to jail.
Seven Network’s former director of program partnerships is suing the national broadcaster for putting her on unpaid maternity leave and extending her non-compete period after she resigned for rival Network Ten.
A federal judge has signed off on a funding agreement in an employment class action against Airservices, even as he acknowledged a pending challenge to a landmark ruling that established the right of the court to make a common fund order.
Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.
The Full Federal Court will hear arguments next week in an appeal by the ACCC over an alleged laundry detergent cartel, the first so-called hub and spoke case brought by the competition regulator.
The CFMMEU must force “systemic behavioural change” on its construction division, a majority Full Federal Court said Tuesday in upholding a fine of $306,000 for workplace breaches against the union and raising the spectre of deregistration.
Consumer goods giant Reckitt Benckiser has been ordered by the Federal Court to remove all in-store advertising for its Strepfen throat lozenges after a successful interlocutory application by rival iNova Pharmaceuticals.
Two ‘sham letters’ produced by a senior manager of national car repair franchise Ultra Tune led both the ACCC and the court ‘down the garden path,’ a Federal Court judge heard Thursday.
The final day of trial in the ACCC’s case over muscle gel Voltaren wrapped up Wednesday with a barrister for GlaxoSmithKline slamming as ‘onerous’ a compliance regime proposed by the consumer watchdog and blasting an injunction as unnecessary for a problem the pharmaceutical giant ‘inherited’ from Novartis.
The first day of a liability hearing in a consumer case over GlaxoSmithKline’s marketing for its popular Voltaren products has seen an ACCC witness deflect accusations the regulator was vague about its misleading packaging concerns, placing the blame squarely on the pharmaceutical giant.